Roth Capital upgraded shares of Green Thumb Industries (OTC:GTBIF – Free Report) to a strong-buy rating in a research report released on Sunday,Zacks.com reports.
A number of other equities analysts also recently issued reports on the company. Ventum Cap Mkts raised Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research report on Monday, September 16th.
Check Out Our Latest Stock Analysis on Green Thumb Industries
Green Thumb Industries Trading Down 12.5 %
Green Thumb Industries Company Profile
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.
Featured Articles
- Five stocks we like better than Green Thumb Industries
- How to Calculate Return on Investment (ROI)
- These 3 Active ETFs Beat the S&P 500 Over the Last Five Years
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
- How to Invest in Biotech Stocks
- Lam Research Fueled by Unyielding AI Demand Growth
Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.